相关实验视频
Updated: Jan 17, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
909
在心脏代谢疾病自我管理中与对话代理启用干预的参与:系统性审查
Nick Kashyap1,2,3, Ann Tresa Sebastian4, Chris Lynch1,3
1School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
JMIR mHealth and uHealth
|September 18, 2025
概括
交谈剂可以改善心脏代谢性疾病 (CMD) 的自我管理. 设计特征,如沟通风格和个性,显著影响用户参与,增强对这些数字健康工具的自主性和投资.
科学领域:
- 数字健康数字健康
- 人与计算机的交互
- 行为科学 行为科学
背景情况:
- 交谈代理商有潜力提高对心脏代谢疾病 (CMD) 自主管理的医疗保健能力.
- 有限的经验证据存在于对话代理启用干预的设计特征及其对用户参与的影响.
- 本综述综合了证据,以指导开发更有吸引力的CMD自我管理干预措施.
研究的目的:
- 综合关于对话代理启用干预的设计特征的证据.
- 检查这些设计特征对CMD患者用户参与度的影响.
主要方法:
- 在奥维德 (MEDLINE),科学网络和Scopus.org上进行系统的文献搜索.
- 包含对对话性代理支持干预措施的初级研究研究与参与措施和成年CMD人群.
- 数据提取的重点是关于各种设计特征的用户观点.
主要成果:
- 包括20项研究,其中18项专注于干预原型的定性或准实验性评估.
- 设计特征影响参与的五个关键领域被确定为:沟通风格,功能,可访问性,视觉外观和个性.
- 冗余和人形主义成为促进参与的有效策略.
结论:
- 将冗余性和人形性整合到对话代理中可以通过促进自主性和投资来提高用户参与度.
- 未来的研究应该优先考虑包容性和适应性设计策略,以适应不同用户需求和干预环境.
- 优化设计特征对于开发有效的对话式代理启用干预措施来实现CMD自我管理至关重要.
相关概念视频
Cardiomyopathy V: Interprofessional Care
339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Nursing Interventions I: Taxonomy of Nursing Interventions
3.6K
Nursing interventions are chosen as part of the planning process to achieve patient outcomes. Once nursing diagnoses are determined, the goals and outcomes are specified, then the nursing interventions are selected and individualized according to the patient's situation.
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
3.6K
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
